(R)-2-(6-Cyclopropylpyridin-2-yl)-4-methyl-4,5-dihydrooxazole
97%
- Product Code: 231853
CAS:
2828438-74-8
| Molecular Weight: | 202.25 g./mol | Molecular Formula: | C₁₂H₁₄N₂O |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, sealed, dry, inert gas |
Product Description:
Used as a key intermediate in the synthesis of Janus kinase (JAK) inhibitors, particularly in the development of pharmaceuticals targeting autoimmune diseases such as rheumatoid arthritis and psoriasis. Its chiral structure enables selective interaction with biological targets, enhancing drug efficacy and reducing side effects. Commonly employed in medicinal chemistry for constructing complex heterocyclic systems in kinase inhibitor pipelines.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 100mg | 10-20 days | ฿10,680.00 |
+
-
|
| 250mg | 10-20 days | ฿18,140.00 |
+
-
|
| 1g | 10-20 days | ฿53,040.00 |
+
-
|
(R)-2-(6-Cyclopropylpyridin-2-yl)-4-methyl-4,5-dihydrooxazole
Used as a key intermediate in the synthesis of Janus kinase (JAK) inhibitors, particularly in the development of pharmaceuticals targeting autoimmune diseases such as rheumatoid arthritis and psoriasis. Its chiral structure enables selective interaction with biological targets, enhancing drug efficacy and reducing side effects. Commonly employed in medicinal chemistry for constructing complex heterocyclic systems in kinase inhibitor pipelines.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :